Reliable Anti-NMDA Receptor Antibody Assay: Trusted by Researchers Worldwide

Sharetry Biotech Co., Ltd. is a leading manufacturer, supplier, and factory of Anti-NMDA receptor antibody assay. Our Anti-NMDA receptor antibody assay is a reliable and sensitive tool designed to detect the presence of autoantibodies against the N-methyl-D-aspartate (NMDA) receptor in serum or cerebrospinal fluid samples. This assay has been optimized to deliver accurate and quantifiable results, enabling clinicians to diagnose the condition and monitor the therapeutic response of patients.

Anti-NMDA receptor antibody assay is a critical tool for diagnosing autoimmune encephalitis, which is an inflammatory disorder of the brain that can cause seizures, behavioral changes, and other neurological symptoms. Early diagnosis is essential to improve patient outcomes, and our Anti-NMDA receptor antibody assay provides fast and accurate results, ensuring prompt diagnosis and treatment.

As a leading biotech company in China, Sharetry Biotech Co., Ltd. is committed to providing high-quality and reliable diagnostic tools to clinicians worldwide. With our Anti-NMDA receptor antibody assay, healthcare professionals can diagnose and treat autoimmune encephalitis with confidence.

Featured Products

  • We are thrilled to introduce our Anti-NMDA Receptor Antibody Assay, a cutting-edge diagnostic tool for the detection of anti-NMDA receptor antibodies in human serum and cerebrospinal fluid (CSF). As a highly sensitive and specific assay, our anti-NMDA receptor antibody test is designed to aid in the diagnosis of autoimmune encephalitis, a rare but serious neurological disorder that can cause inflammation and damage to the brain. This test is particularly beneficial for assessing patients who present with neuropsychiatric symptoms, such as seizures, memory loss, mood changes, and movement disorders, as well as those with suspected paraneoplastic neurological syndromes. Our assay utilizes a proprietary enzyme-linked immunosorbent assay (ELISA) technology, which enables the rapid and accurate measurement of IgG antibodies against the NR1 subunit of the NMDA receptor. By using a standardized antigenic substrate and optimized assay conditions, we are able to achieve excellent specificity, sensitivity, and reproducibility, allowing for confident clinical decision-making and improved patient outcomes. We are committed to providing high-quality and reliable diagnostic tools that meet the evolving needs of healthcare professionals and improve the lives of patients. Our Anti-NMDA Receptor Antibody Assay is a testament to this commitment and represents a significant advancement in the field of neurology.

  • Advantages of Point of Care Testing for Convenient and Quick Results

    Sharetry, a high-tech enterprise specializing in the integration of research and development, registration, manufacture, sales, and market resources of medical devices and in vitro diagnostic devices,

  • Herpes Simplex Virus 1 IgM Kit for Virology Studies Available

    article on the launch of the Biognost Herpes Simplex Virus 1 (HSV 1) IgM Kit. Sharetry Launches Biognost Herpes Simplex Virus 1 (HSV 1) IgM Kit Sharetry, a high-tech enterprise specializing in medic

  • IL-6 Inhibitors Show Promise for COVID-19 Treatment in Clinical Trials

    According to the latest news, IL-6 inhibitors are being tested as a potential therapy for COVID-19. This class of drugs has shown promise in reducing the severity of the virus by blocking the activity

  • The Anatomy of the Hamster Cheek Pouch Epithelium: A Study.

    article on the importance of understanding the surface structure of epithelium in medical research. Understanding the surface structure of epithelium is of critical importance in medical research. Ep
    • ;
Autoimmune blood test, China CLIA Assay, Instrument for immunoassay analysis, Drug Rapid Viral Test, Peach Component F420, IgE immunoassay kit, Protein detection reagents, Aldosterone, China Test Strip, Rubella Virus Igg,